- enrolling by invitation
Long-Term Follow-up: Phase I/II Clinical Study to Evaluate the Safety and Efficacy of the Infusion of RP-L102
This study is checking on people who received a special treatment called RP-L102 for Fanconi Anaemia. It aims to see how safe and effective the treatment is over many years. If you were part of a previous RP-L102 study, you might be able to join this one.
United States · Spain · United Kingdom - recruitingPHASE1, PHASE2
Afatinib in Patients With Fanconi Anemia (FA) and Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)
This study is testing a drug called Afatinib for people with Head and Neck cancer who also have Fanconi Anemia. We want to see if it's safe and helps control the cancer. This is an early-stage study to learn more about this drug in this specific group of patients.
Germany · Spain